Malaysia’s Xeraya Capital invests in GreenLight Biosciences’ $102m Series D round

Malaysia’s Xeraya Capital invests in GreenLight Biosciences’ $102m Series D round

Xeraya Capital CEO Fares Zahir

18 June, 2020

Printed by Unregistered user on Sun, 13 Jul 2025 10:06:31 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Malaysia’s Xeraya Capital joins $120m round for US-based Rapid Micro Biosystems

Malaysia’s Xeraya Capital leads $31m Series B round for US medical device maker Aria CV

Read more from Malaysia

Premier of Malaysia’s Sarawak sees sovereign fund role for oil major Petros

AirAsia talks with investors near conclusion, says deputy CEO